Benign metastasizing leiomyoma (BML) is a rare disease that usually occurs in women of reproductive age. They typically have history of uterine leiomyoma treated with hysterectomy. BML can metastasize to distant organs, with the lung being the most common organ. We report two patients who presented with benign metastasizing leiomyoma to the lung. Our first case was a fifty-two-year-old female who presented with multiple lung masses, with a past medical history of uterine leiomyoma who underwent hysterectomy 17 years ago. A CT-guided biopsy showed benign appearing spindle cells and pathology confirmed her diagnosis with additional positive estrogen/progesterone receptor stains. Our second case was a fifty-six-year-old female who presented with multiple cavitary pulmonary nodules. She subsequently underwent a video-assisted thoracoscopic surgery (VATS) with wedge resection of one of the nodules. Pathology confirmed the diagnosis based on morphology and immunohistochemical staining strongly positive for estrogen/progesterone receptors. Benign metastasizing leiomyoma is a rare condition which may affect women of reproductive age. This should be considered in the differential in patients who present with multiple pulmonary nodules, especially with a history of uterine leiomyoma. Additional stains, such as estrogen/progesterone receptors, may need to be done to confirm the diagnosis. 1. Introduction Benign metastasizing leiomyoma (BML) represents a rare disease entity. This may present as lesions in lymph nodes, deep soft tissues, mesentery, bones, central nervous system, and heart. However, the most commonly affected organ is the lung; thus, it might be confused with leiomyosarcoma [1]. BMLs occur most commonly in women during their reproductive years. The preponderance of diagnosis happens in patients who develop new pulmonary nodules many years after the removal of the uterus for leiomyoma [2–11]. Here we report two patients who presented with the unusual presentation of benign metastasizing leiomyomas to the lungs. 2. Report of Two Cases 2.1. First Case A fifty-two-year-old female presented with abdominal pain. An abdominal computed tomography (CT) scan demonstrated a right lower lobe mass. She then underwent a chest CT which showed a right lower lobe (RLL) mass (3.9 × 3.5?cm) with numerous smaller nodules throughout both lungs (CT, Figure 1). A positron emission tomography (PET) scan showed positive uptake in the larger right lower lobe nodule and a left lower lobe nodule. Her medical history included a hysterectomy for a benign leiomyoma 17 years ago.
References
[1]
J. A. Rivera, S. Christopoulos, D. Small, and M. Trifiro, “Hormonal manipulation of benign metastasizing leiomyomas: report of two cases and review of the literature,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 7, pp. 3183–3188, 2004.
[2]
M. R. Abell and E. R. Littler, “Benign metastasizing uterine leiomyoma. Multiple lymph nodal metastases,” Cancer, vol. 36, no. 6, pp. 2206–2213, 1975.
[3]
V. Canzonieri, E. S. D'Amore, G. Bartoloni, M. Piazza, S. Blandamura, and A. Carbone, “Leiomyomatosis with vascular invasion. A unified pathogenesis regarding leiomyoma with vascular microinvasion, benign metastasizing leiomyoma and intravenous leiomyomatosis,” Virchows Archiv, vol. 425, no. 5, pp. 541–545, 1994.
[4]
J. M. Esteban, W. M. Allen, and R. H. Schaerf, “Benign metastasizing leiomyoma of the uterus: histologic and immunohistochemical characterization of primary and metastatic lesions,” Archives of Pathology and Laboratory Medicine, vol. 123, no. 10, pp. 960–962, 1999.
[5]
G. Jautzke, E. Müller-Ruchholtz, and U. Thalmann, “Immunohistological detection of estrogen and progesterone receptors in multiple and well differentiated leiomyomatous lung tumors in women with uterine leiomyomas (so-called benign metastasizing leiomyomas): a report on 5 cases,” Pathology Research and Practice, vol. 192, no. 3, pp. 215–223, 1996.
[6]
K. Kayser, S. Zink, T. Schneider et al., “Benign metastasizing leiomyoma of the uterus: documentation of clinical, immunohistochemical and lectin-histochemical data of ten cases,” Virchows Archiv, vol. 437, no. 3, pp. 284–292, 2000.
[7]
D. M. Koh, P. R. Burn, and D. M. King, “Benign metastasizing leiomyoma with intracaval leiomyomatosis,” British Journal of Radiology, vol. 73, no. 868, pp. 435–437, 2000.
[8]
M. R. Nucci, R. Drapkin, P. D. Cin, C. D. M. Fletcher, and J. A. Fletcher, “Distinctive cytogenetic profile in benign metastasizing leiomyoma: pathogenetic implications,” American Journal of Surgical Pathology, vol. 31, no. 5, pp. 737–743, 2007.
[9]
K. T. Patton, L. Cheng, V. Papavero et al., “Benign metastasizing leiomyoma: clonality, telomere length and clinicopathologic analysis,” Modern Pathology, vol. 19, no. 1, pp. 130–140, 2006.
[10]
L. Tietze, K. Günther, A. H?rbe et al., “Benign metastasizing leiomyoma: a cytogenetically balanced but clonal disease,” Human Pathology, vol. 31, no. 1, pp. 126–128, 2000.
[11]
M. Wolff, G. Kaye, and F. Silva, “Pulmonary metastases (with admixed epithelial elements) from smooth muscle neoplasms. Report of nine cases, including three males,” American Journal of Surgical Pathology, vol. 3, no. 4, pp. 325–342, 1979.
[12]
S. Y. Lim, J. C. Park, J. G. Bae, et al., “Pulmonary and retroperitoneal benign metastasizing leiomyoma,” Clinical and Experimental Reproductive Medicine, vol. 38, no. 3, pp. 174–177, 2011.
[13]
S. W. Bell, R. L. Kempson, and M. R. Hendrickson, “Problematic uterine smooth muscle neoplasms: a clinicopathologic study of 213 cases,” American Journal of Surgical Pathology, vol. 18, no. 6, pp. 535–558, 1994.